Clinical Effectiveness of Atrial Anti-tachycardia Pacing Therapy in Sick Sinus Syndrome with Previous Atrial Fibrillation Ablation (CEASE-AF)
- Conditions
- Sick sinus syndromeAtrial FibrillationCardiovascular - Other cardiovascular diseases
- Registration Number
- ACTRN12616001353482
- Lead Sponsor
- Centre for Heart Rhythm Disorders, University of Adelaide, Royal Adelaide Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 136
a.The patient has a dual chamber pacemaker capable of atrial anti-tachycardia based therapy,
b.Had AF ablation at least 3 months prior to recruitment,
c.AF/atrial arrhythmia burden >0.1% and <30%,
d.greater than or equal to 18 years of age
a.Atrioventricular block with ventricular pacing >40 percent,
b.Atrial fibrillation episode >90 days. However, presence of prolonged episodes of atrial flutter will not be an exclusion corner,
c.Absence of indication for cardiac resynchronization or defibrillator,
d.Had < 12 months of life expectancy,
e.Cardiac surgery in the last six months, or expected during 12 months of study period,
f.A recent history of (< 1 year) or current malignancy, advanced heart failure (NYHA class IV), end-stage chronic obstructive pulmonary disease or other severe life-threatening comorbidities within 3 months of diagnosis, or
g.Unable to provide consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method